BRPI0718533B8 - composição compreendendo ácido rosmarínico e micro-organismo contendo ou produzindo enzima hidrolítica, seu uso e processo para preparar composição tendo bioeficácia aumentada - Google Patents

composição compreendendo ácido rosmarínico e micro-organismo contendo ou produzindo enzima hidrolítica, seu uso e processo para preparar composição tendo bioeficácia aumentada

Info

Publication number
BRPI0718533B8
BRPI0718533B8 BRPI0718533A BRPI0718533A BRPI0718533B8 BR PI0718533 B8 BRPI0718533 B8 BR PI0718533B8 BR PI0718533 A BRPI0718533 A BR PI0718533A BR PI0718533 A BRPI0718533 A BR PI0718533A BR PI0718533 B8 BRPI0718533 B8 BR PI0718533B8
Authority
BR
Brazil
Prior art keywords
composition
rosmarinic acid
microorganism containing
hydrolytic enzyme
preparing
Prior art date
Application number
BRPI0718533A
Other languages
English (en)
Inventor
Castiel Isabelle
Page Nicolas
Bel-Rhlid Rachid
Raab Thomas
Crespy Vanessa
Original Assignee
Loreal Loreal S A
Nestec Sa
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Loreal Loreal S A, Nestec Sa, Nestle Sa filed Critical Loreal Loreal S A
Publication of BRPI0718533A2 publication Critical patent/BRPI0718533A2/pt
Publication of BRPI0718533B1 publication Critical patent/BRPI0718533B1/pt
Publication of BRPI0718533B8 publication Critical patent/BRPI0718533B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/14—Yeasts or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
    • A23L31/10—Yeasts or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

composições compreendendo ácido rosmarínico, uso das mesmas, uso de uma enzima hidrolítica ou um micro-organismo contendo ou produzindo a dita enzima e processo para o preparo de uma composição que tem uma bioeficácia aumentada. a presente invenção refere-se às composições, que compreendem o ácido rosmarínico e/ou seus derivados e ao uso de uma enzima hidrolítica ou de um micro-organismo contendo ou produzindo enzimas hidrolíticas nessas composições. a invenção também pertence aos métodos para melhorar os efeitos biológicos dos ditos extratos de alecrim.
BRPI0718533A 2006-11-06 2007-11-06 composição compreendendo ácido rosmarínico e micro-organismo contendo ou produzindo enzima hidrolítica, seu uso e processo para preparar composição tendo bioeficácia aumentada BRPI0718533B8 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP06023060.4 2006-11-06
EP06023060A EP1917960A1 (en) 2006-11-06 2006-11-06 Improved biological effects of rosmarinic acid
US86961506P 2006-12-12 2006-12-12
US60/869,615 2006-12-12
PCT/EP2007/009602 WO2008055651A1 (en) 2006-11-06 2007-11-06 Improved biological effects of compositions comprising rosmarinic acid

Publications (3)

Publication Number Publication Date
BRPI0718533A2 BRPI0718533A2 (pt) 2013-11-26
BRPI0718533B1 BRPI0718533B1 (pt) 2020-08-18
BRPI0718533B8 true BRPI0718533B8 (pt) 2021-05-25

Family

ID=37814047

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0718533A BRPI0718533B8 (pt) 2006-11-06 2007-11-06 composição compreendendo ácido rosmarínico e micro-organismo contendo ou produzindo enzima hidrolítica, seu uso e processo para preparar composição tendo bioeficácia aumentada

Country Status (14)

Country Link
US (2) US8932579B2 (pt)
EP (2) EP1917960A1 (pt)
CN (1) CN101563078B (pt)
AR (1) AR063570A1 (pt)
AT (1) ATE461699T1 (pt)
AU (1) AU2007316954B2 (pt)
BR (1) BRPI0718533B8 (pt)
CA (1) CA2668472C (pt)
CL (1) CL2007003203A1 (pt)
DE (1) DE602007005506D1 (pt)
ES (1) ES2344127T3 (pt)
MX (1) MX2009004739A (pt)
TW (1) TWI494101B (pt)
WO (1) WO2008055651A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2210504A1 (en) * 2009-01-27 2010-07-28 Nestec S.A. Composition comprising chicoric acid and/or derivatives thereof
CA2839524C (en) 2011-06-20 2016-05-17 H.J. Heinz Company Probiotic compositions and methods
EP2863929B1 (en) 2012-06-22 2016-07-20 Nestec S.A. Probiotic and polyphenol against neurodegeneration
CA2884745A1 (en) * 2012-09-21 2014-03-27 Nestec S.A. Composition comprising plant phenols for preventing or reducing tewl and associated disorders and diseases
EP2897606B1 (en) * 2012-09-21 2020-05-06 Société des Produits Nestlé S.A. Plant phenols and their use in the treatment or prevention of eosinophilic esophagitis
CN103083207A (zh) * 2013-01-18 2013-05-08 吉林农业大学 皮肤营养护理液
EP3091851A1 (en) * 2013-12-20 2016-11-16 Abbott Laboratories Nutritional composition containing oxidizable oil and rosmarinic acid
RU2552790C1 (ru) * 2014-01-13 2015-06-10 Федеральное государственное бюджетное учреждение науки Институт биологии Коми научного центра Уральского отделения Российской академии наук Противоожоговая композиция
US20150327718A1 (en) 2014-02-14 2015-11-19 Remington Designs, Llc Apparatuses and methods for solute extraction
WO2015196099A1 (en) * 2014-06-19 2015-12-23 Kemin Industries, Inc. Ingredients for delaying milk fat oxidation
MX2017004582A (es) * 2014-10-08 2017-10-12 Abbott Lab Composiciones nutricionales que comprenden un componente oxidable y un extracto de plantas solubles en agua.
WO2016090436A1 (en) * 2014-12-11 2016-06-16 Saluda Medical Pty Ltd Method and device for feedback control of neural stimulation
CN105475990B (zh) * 2015-11-30 2019-10-08 杭州鑫伟低碳技术研发有限公司 一种灵芝孢子粉或灵芝多糖悬浮凝胶的制造方法
CN106360727B (zh) * 2016-11-22 2023-06-27 江南大学 一种植物的综合利用方法
CN106578403B (zh) * 2016-12-07 2020-12-01 江南大学 紫苏籽粕的综合利用方法
EP3780975B1 (en) * 2018-04-17 2022-08-10 Protea Biopharma N.V. Sustained energy providing and free radical protective composition
KR102040972B1 (ko) * 2018-09-14 2019-11-05 마이크로바이오주식회사 피부 노화 방지 또는 주름 개선 활성이 있는 신규한 비피도박테리움 락티스(Bifidobacterium lactis) UBC-U04 및 이를 이용한 조성물
CN110172493A (zh) * 2019-05-28 2019-08-27 湖南中医药大学 一种咖啡酸的制备方法
CN114288333B (zh) * 2021-12-28 2022-10-21 中国科学院植物研究所 一种抑制皮肤黑素瘤细胞增殖的迷迭香复方精油及其用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE172245T1 (de) * 1992-07-06 1998-10-15 Nestle Sa Milchbakterien
US6245363B1 (en) * 1995-06-07 2001-06-12 Zylepsis Limited Methods of treating plant materials with hydrolytic enzymes isolated from humicola species
FR2755368B1 (fr) * 1996-11-04 1999-03-19 Oreal Composition rincable pour le soin de la peau
FR2788435B1 (fr) * 1999-01-15 2002-08-02 Oreal Utilisation d'un extrait d'un vegetal du genre rosmarinus dans des compositions destinees a traiter les signes cutanes du vieillissement
EP1110555A1 (fr) * 1999-12-22 2001-06-27 Societe Des Produits Nestle S.A. Agent anti-adhesion de la flore pathogene de la peau
EP1151673A3 (en) 2000-05-03 2002-01-02 Societe Des Produits Nestle S.A. Confectionery product having a filling
WO2002047701A1 (en) * 2000-12-12 2002-06-20 Angiolab, Inc. Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity
KR20030082764A (ko) * 2002-04-18 2003-10-23 에스케이케미칼주식회사 관절조직 보호 작용을 갖는 생약조성물
AU2003284985A1 (en) * 2002-10-23 2004-05-13 Rutgers, The State University Of New Jersey Production of vanillin in microbial cells
FR2848851B1 (fr) * 2002-12-20 2006-03-10 Procede d'obtention d'un principe actif presentant des capacites apaisantes, principe actif et compositions obtenues
US20050037094A1 (en) * 2003-07-31 2005-02-17 Xijun Yan Composition for heart disease, its active ingredients, method to prepare same and uses thereof
US20060018867A1 (en) * 2004-05-12 2006-01-26 Ichimaru Pharcos Co., Ltd Cosmetic composition and production thereof
US20060269508A1 (en) * 2005-03-29 2006-11-30 Trejo Amy V Means for regulating the cosmetic appearance and/or health of human keratinous tissue
EP2210504A1 (en) * 2009-01-27 2010-07-28 Nestec S.A. Composition comprising chicoric acid and/or derivatives thereof

Also Published As

Publication number Publication date
BRPI0718533A2 (pt) 2013-11-26
ATE461699T1 (de) 2010-04-15
WO2008055651A1 (en) 2008-05-15
AU2007316954A1 (en) 2008-05-15
DE602007005506D1 (de) 2010-05-06
US9314490B2 (en) 2016-04-19
EP1917960A1 (en) 2008-05-07
MX2009004739A (es) 2009-07-17
CL2007003203A1 (es) 2008-07-04
EP2081566B1 (en) 2010-03-24
CN101563078B (zh) 2015-01-21
AU2007316954B2 (en) 2013-04-18
CA2668472C (en) 2015-04-07
US20140023625A1 (en) 2014-01-23
CA2668472A1 (en) 2008-05-15
AR063570A1 (es) 2009-02-04
EP2081566A1 (en) 2009-07-29
US8932579B2 (en) 2015-01-13
BRPI0718533B1 (pt) 2020-08-18
US20100129324A1 (en) 2010-05-27
TW200829233A (en) 2008-07-16
CN101563078A (zh) 2009-10-21
ES2344127T3 (es) 2010-08-18
TWI494101B (zh) 2015-08-01

Similar Documents

Publication Publication Date Title
MX2009004739A (es) Efectos biologicos mejorados de composiciones que comprenden acido rosmarinico.
BRPI0801858A2 (pt) uso de pelo menos um meio de cultura celular condicionado ou de seu extrato e composiÇço cosmÉtica ou dermatolàgica
BRPI0802049A2 (pt) composiÇço cosmÉtica ou dermatolàgica, usos de pelo menos um meio de cultura celular, processo cosmÉtico para melhorar a homeostase cutÂnea e processo para preparar uma composiÇço cosmÉtica ou dermatolàgica
DE602006004719D1 (de) Verfahren zur herstellung von cellulosesulfat mit verbesserten eigenschaften
Huang et al. Biosynthesis of valonia tannin hydrolase and hydrolysis of valonia tannin to ellagic acid by Aspergillus SHL 6
BR112012032979B8 (pt) Composição para limpeza da pele límpida, de baixa irritação, e com ph relativamente baixo e método de limpeza da pele
BRPI0910439B8 (pt) derivados de tienopiridona como ativadores da proteína quinase ativada por amp (ampk), seu processo de preparação, e medicamentos
Kolayli et al. Honey shows potent inhibitory activity against the bovine testes hyaluronidase
BR112016005228A8 (pt) Uso de uma ou mais glicosidases e processo para produzir um oligossacarídeo
BRPI1009842B8 (pt) uso de agonista de tlr9 e agonista de tlr2/6 na preparação de uma composição farmacêutica para tratamento, inibição ou atenuação de uma infecção microbiana, bem como composição farmaceuticamente aceitável compreendendo os referidos agonistas
BR112013005679A2 (pt) imidazopiridazinas substituídas
BRPI0914536A8 (pt) Tiadiazoliloxifenilamidinas, processo para sua preparação e seus usos, composição e processo para combater microorganismos indesejáveis, e semente resistente a microorganismos indesejáveis
BR112014004687A2 (pt) imidazopiridazinas amino-substituídas
MY152105A (en) Hemicellulase enriched compositions for enhancing hydrolysis of biomass
BR112012020277A2 (pt) "enzimas celulase otimizadas".
BR112013002377A2 (pt) método para degradar ou hidrolisar um polissacarídeo, para produzir sacarídeos solúveis e para produzir uma substância orgânica, e, processo para produzir um produto de fermentação.
BRPI0609278B8 (pt) método para preparar uma composição farmacêutica e composição farmacêutica
Son et al. Comparison of α‑glucosidase inhibition by Cudrania tricuspidata according to harvesting time
WO2008019069A3 (en) Enzymatic aqueous acylation
BR112014013958A2 (pt) ácidos piperidinila naftilacéticos
BR112015009192A2 (pt) composições compreendendo um agente de controle biológico e um inseticida
BRPI0914244A2 (pt) Enzima com atividade contra clostridium
Berfilamen et al. In vitro antifungal activities and phytochemical analysis of filamentous white-rot fungi, Schizophyllum commune
BRPI0908569B8 (pt) estimuladores de secreção de insulina derivados de piridopirazinonas, seu uso, e composição farmacêutica
BR112021026537A2 (pt) Combinações de partículas de inorgânicas de éster de ácido graxo de sacarídeo

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B25A Requested transfer of rights approved

Owner name: L'OREAL (L'OREAL S.A.) (FR) ; SOCIETE DES PRODUITS

Owner name: L'OREAL (L'OREAL S.A.) (FR) ; SOCIETE DES PRODUITS NESTLE S.A. (CH)

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 18/08/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 06/11/2007 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 14A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2643 DE 31-08-2021 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.